(Q44601133)

4 December 2017

title

An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probe (English)

1 reference

4 December 2017

An Evaluation of the Dose‐Dependent Inhibition of CYP1A2 by Rofecoxib Using Theophylline as a CYP1A2 Probe (English)

1 reference

https://api.crossref.org/works/10.1177/0091270003257454

dose-response relationship

15 March 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517190

cytochrome P-450 CYP1A2 Inhibitors

15 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517190

15 March 2024

1 reference

https://api.crossref.org/works/10.1177/0091270003257454

15 March 2024

author name string

Kenneth Bachmann

1

1 reference

4 December 2017

Donald White

2

1 reference

4 December 2017

Luis Jauregui

3

1 reference

4 December 2017

Ralph Mazenko

6

1 reference

4 December 2017

Jules I. Schwartz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517190

15 March 2024

Nancy G. B. Agrawal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517190

15 March 2024

Patrick J. Larson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517190

15 March 2024

Arturo G. Porras

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14517190

15 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14517190

15 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1177%2F0091270003257454

1 reference

https://api.crossref.org/works/10.1177/0091270003257454

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1177/0091270003257454

15 March 2024

1 reference

https://api.crossref.org/works/10.1177/0091270003257454

The Journal of Clinical Pharmacology

15 March 2024

published in

1 reference

4 December 2017

volume

43

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1082-1090

1 reference

Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Involvement of tyrosine kinase in the induction of cyclo-oxygenase and nitric oxide synthase by endotoxin in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Where is the evidence that cyclooxygenase inhibition is the primary cause of nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Predicting the ciprofloxacin-theophylline interaction from single plasma theophylline measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Pharmacokinetic changes of theophylline and amikacin through the menstrual cycle in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Determination of rofecoxib, a cyclooxygenase-2 specific inhibitor, in human plasma using high-performance liquid chromatography with post-column photochemical derivatization and fluorescence detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Symmetrical confidence intervals for bioequivalence trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Kinetics of intravenous theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Theophylline kinetics: dose dependency and single sample prediction of clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

A simple method for determination of antipyrine clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003257454

Human P450 metabolism of warfarin

21 January 2018

11

1 reference

https://api.crossref.org/works/10.1177/0091270003257454

Absolute bioavailability of oral theophylline

15 March 2024

21

1 reference

https://api.crossref.org/works/10.1177/0091270003257454

15 March 2024

Identifiers

1 reference

4 December 2017

1 reference